ACUTA CAPITAL PARTNERS, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$99.4B
Holdings
39
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (39 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | OCULOCULAR THERAPEUTIX INC | 1,111,071 | $9.5B | 9.55% | |
| 2 | IM8NINSMED INC | 104,800 | $7.2B | 7.28% | |
| 3 | TRMLTOURMALINE BIO INC | 351,842 | $7.1B | 7.18% | |
| 4 | CRNXCRINETICS PHARMACEUTICALS IN | 122,900 | $6.3B | 6.32% | |
| 5 | ELVNENLIVEN THERAPEUTICS INC | 267,368 | $6.0B | 6.05% | |
| 6 | WHWKAADI BIOSCIENCES INC | 1,849,402 | $5.8B | 5.87% | |
| 7 | PRAXPRAXIS PRECISION MEDICINES I | 67,500 | $5.2B | 5.23% | |
| 8 | RVMDREVOLUTION MEDICINES INC | 111,700 | $4.9B | 4.92% | |
| 9 | ARGXARGENX SE | 6,910 | $4.2B | 4.28% | |
| 10 | PCVXVAXCYTE INC | 45,000 | $3.7B | 3.71% | |
| 11 | TRVITREVI THERAPEUTICS INC | 771,958 | $3.2B | 3.20% | |
| 12 | ASNDASCENDIS PHA-ADR | 22,976 | $3.2B | 3.18% | |
| 13 | MREOMEREO BIOPHARMA GROUP PL-ADR | 779,308 | $2.7B | 2.74% | |
| 14 | DRUGBRIGHT MINDS BIOSCIENCES INC | 69,124 | $2.5B | 2.50% | |
| 15 | TERNTERNS PHARMACEUTICALS INC | 447,500 | $2.5B | 2.49% | |
| 16 | EWTXEDGEWISE THERAPEUTICS INC | 87,658 | $2.3B | 2.35% | |
| 17 | HLXCHELIX ACQUISITION CORP II | 180,945 | $1.9B | 1.91% | |
| 18 | UNCYUNICYCIVE THERAPEUTICS INC | 2,303,000 | $1.8B | 1.84% | |
| 19 | RCKTROCKET PHARMACEUTICALS INC | 134,500 | $1.7B | 1.70% | |
| 20 | LQDALIQUIDIA CORPORATION | 137,709 | $1.6B | 1.63% | |
| 21 | —MERSANA THERAPEUTICS INC | 1,120,500 | $1.6B | 1.61% | |
| 22 | TSHATAYSHA GENE THERAPIES INC | 884,244 | $1.5B | 1.54% | |
| 23 | TECXTECTONIC THERAPEUTIC INC | 33,008 | $1.5B | 1.53% | |
| 24 | CDTXCIDARA THERAPEUTICS INC | 54,473 | $1.5B | 1.47% | |
| 25 | NAMSNEWAMSTERDAM PHARMA CO NV | 50,000 | $1.3B | 1.29% | |
| 26 | ZYMEZYMEWORKS INC | 67,240 | $984.4M | 0.99% | |
| 27 | ELDNELEDON PHARMACEUTICALS INC | 235,750 | $971.3M | 0.98% | |
| 28 | VERVVERVE THERAPEUTICS INC | 160,200 | $903.5M | 0.91% | |
| 29 | RAREULTRAGENYX PHARMACEUTICAL INC | 21,000 | $883.5M | 0.89% | |
| 30 | GILDGILEAD SCIENCES INC | 9,150 | $845.2M | 0.85% | |
| 31 | ACLXARCELLX INC | 10,743 | $823.9M | 0.83% | |
| 32 | GBYSANGAMO THERAPEUTICS INC | 740,000 | $754.8M | 0.76% | |
| 33 | THRDTHIRD HARMONIC BIO INC | 49,800 | $512.4M | 0.52% | |
| 34 | ARTVARTIVA BIOTHERAPEUTICS INC | 44,000 | $443.5M | 0.45% | |
| 35 | FBRXFORTE BIOSCIENCES INC | 18,139 | $411.9M | 0.41% | |
| 36 | CRVSCORVUS PHARMACEUTICALS INC | 74,307 | $397.5M | 0.40% | |
| 37 | CELCCELCUITY INC | 25,000 | $327.3M | 0.33% | |
| 38 | RAPPRAPPORT THERAPEUTICS INC | 16,400 | $290.9M | 0.29% | |
| 39 | NUVB/WSNUVATION BIO INC -CW27 | 90,832 | $20.9M | 0.02% |